Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Injection of hydrocortisone acetate into shoulder joint |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Injection of hydrocortisone acetate into ankle joint |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Injection of hydrocortisone acetate into knee joint (procedure) |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 100 mg/mL rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 25 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 25mg/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 2.5% eye ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 10 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate [topical] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 2.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone 10 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 0.5% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone 1% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 50mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Colistin sulfate + hydrocortisone acetate + neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 20 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Subcutaneous injection of hydrocortisone acetate |
Direct substance |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate + pramoxine hydrochloride 1%wv/1%wv lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate + pramoxine hydrochloride 1%ww/1%ww aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 25 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Injection of hydrocortisone acetate into ankle joint |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Injection of hydrocortisone acetate into shoulder joint |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Injection of hydrocortisone acetate into knee joint (procedure) |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone 1% / Pramocaine 1% foam enema (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Subcutaneous injection of hydrocortisone acetate |
Direct substance |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 50mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate 50mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone acetate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone acetate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone acetate in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone acetate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
Has precise active ingredient |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 10 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 10 mg/g cutaneous ointment |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
Has precise active ingredient |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 5 mg/g eye ointment |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 5 mg/g eye ointment |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 2.5% eye ointment (substance) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 2.5% eye ointment (substance) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has basis of strength substance (attribute) |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has precise active ingredient |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops |
Has precise active ingredient |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops |
Has basis of strength substance (attribute) |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
Has basis of strength substance (attribute) |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
Has precise active ingredient |
False |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 25 mg/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 25 mg/mL suspension for injection |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 25 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 25 mg rectal suppository |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 20 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 20 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 100 mg/mL rectal foam |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 100 mg/mL rectal foam |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 25 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 25 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 20 mg/mL cutaneous lotion |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 20 mg/mL cutaneous lotion |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone (as hydrocortisone acetate) 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
Has precise active ingredient |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Hydrocortisone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |